Literature DB >> 2912956

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

T Girinski1, M H Pejovic-Lenfant, J Bourhis, F Campana, J M Cosset, C Petit, E P Malaise, C Haie, A Gerbaulet, D Chassagne.   

Abstract

A retrospective study was carried out on 386 patients with advanced cervical carcinomas treated with radiation therapy between 1973 and 1983. The influence of hemoglobin concentrations and blood transfusions before and/or during treatment on the occurrence of distant and/or local regional failures were examined in a univariate and multivariate analyses. In the multivariate analysis hemoglobin concentrations were prognostic only during treatment and patients with at least one value below the threshold of 10 gm% had a significantly higher risk of local regional failure than the patients with all their values above the threshold. Moreover 70% of these high risk patients had less than half of their values below the threshold. It is possible that blood transfusions might be beneficial when given before treatment. However, although it was not significant, blood transfusions given during treatment tended to be an adverse prognostic factor suggesting that blood transfusions might not have completely offset acute anemia prior to transfusion. Our study suggests that anemia during treatment, even of short duration might be detrimental to patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912956     DOI: 10.1016/0360-3016(89)90007-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Impact of anemia in patients with head and neck cancer treated with radiation therapy.

Authors:  Kenneth Hu; Louis B Harrison
Journal:  Curr Treat Options Oncol       Date:  2005-01

2.  Anemia in cervical cancer patients: implications for iron supplementation therapy.

Authors:  Myrna Candelaria; Lucely Cetina; Alfonso Dueñas-González
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients.

Authors:  Xianren Ye; Jingfu Liu; Yujuan Chen; Na Wang; Rong Lu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Hypoxia and anaemia in patients with cancer of the uterine cervix.

Authors:  Francisco José Andreu-Martínez; Julia M Martínez-Mateu
Journal:  Clin Transl Oncol       Date:  2005-09       Impact factor: 3.405

Review 5.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

6.  Oxygen distributions partly explain the radiation response of human squamous cell carcinomas.

Authors:  P Okunieff; J de Bie; E P Dunphy; D J Terris; M Höckel
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 7.  Indications for and complications of transfusion and the management of gynecologic malignancies.

Authors:  Paulina Cybulska; Cheryl Goss; William P Tew; Rekha Parameswaran; Yukio Sonoda
Journal:  Gynecol Oncol       Date:  2017-05-18       Impact factor: 5.482

8.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

9.  The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.

Authors:  Heidi J Gray; Erin Seifert; Victor G Sal Y Rosas; Katrina F Nicandri; Wui-Jin Koh; Barbara A Goff
Journal:  Obstet Gynecol Int       Date:  2010-04-28

10.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.